Ranbaxy UK unit recalls painkiller-paper

The British unit of Indian drugmaker Ranbaxy is recalling all unused stock of a batch of a nerve pain treatment after failing to update mandatory safety information, the DNA Money newspaper reported on Saturday.

The British unit of Indian drugmaker Ranbaxy is recalling all unused stock of a batch of a nerve pain treatment after failing to update mandatory safety information, the DNA Money newspaper reported on Saturday.

HT Image

Ranbaxy is working to update the safety information on the generic Gabapentin, the newspaper quoted Makoto Kihara, a spokesman for Japan's Daiichi Sankyo, which owns a msjority stake in Ranbaxy.

Kihara declined to comment on any earnings impact the recall might have, the newspaper reported.